awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26830522-88F743E1-2609-420E-9115-28937332B8B2
Q26830522-88F743E1-2609-420E-9115-28937332B8B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830522-88F743E1-2609-420E-9115-28937332B8B2
Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
P2860
Q26830522-88F743E1-2609-420E-9115-28937332B8B2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830522-88F743E1-2609-420E-9115-28937332B8B2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7476d4786fb1da2cffdaf6c84a833e5ac47d11dc
P2860
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer